Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
GU tumors
Jul 24, 2024, 13:13 |
Blog
Earle Burgess: Bipolar androgen therapy for advanced prostate cancer
Earle Burgess, Genitourinary Medical Oncologist, Atrium Health Levine Cancer Institute, shared on LinkedIn: "Bipolar androgen therapy…
Jul 24, 2024, 01:00 |
Blog
Chiara Corti: Over 1,900 downloads for our educational chapter on systemic therapy in breast cancer
Chiara Corti shared a post on LinkedIn about a recent paper titled "Systemic Therapy in Breast…
Jul 24, 2024, 00:54 |
Blog
12 leaders selected for the 2024-2025 ASCO Leadership Development Program
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "We congratulate the 12…
Jul 23, 2024, 15:52 |
Drugs
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
In the rapidly evolving field of oncology, we are witnessing remarkable advancements in various treatment…
Jul 22, 2024, 08:58 |
Blog
Tumor-Type Prediction Using Targeted Clinical Genomic Sequencing Data
Maria Natalia Gandur Quiroga shared on X: "Deep-Learning Model for Tumor-Type Prediction Using Targeted Clinical Genomic…
Jul 22, 2024, 08:16 |
Blog
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation
Maria Natalia Gandur Quiroga shared on X: "Key Findings from the Study on Synergistic Effects of…
Jul 21, 2024, 21:47 |
Blog
Cássio Murilo T. Hidalgo Filho: Unplanned hospitalization among cancer patients in the Brazilian health system
Cássio Murilo T. Hidalgo Filho, Medical Oncology fellow at Cancer Institute of the State of…
Jul 21, 2024, 13:36 |
Blog
Rami Manochakian: Neoadjuvant osimertinib in stage I-IIIA EGFRm NSCLC did not meet primary endpoint
Rami Manochakian shared a post on X: ''Hot off the press. Neoadjuvant Osimertinib for the…
Jul 21, 2024, 12:10 |
Blog
invIOs selects lead candidate to IND-enable studies in glioblastoma and melanoma
invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, announced that…
Jul 20, 2024, 20:59 |
Blog
Patrick Hwu: Enjoyed joining my fellow Tampa Bay CEOs
Patrick Hwu shared a post on X: . "Enjoyed joining my fellow Tampa Bay CEOs…
35
36
37
38
39
All:
738
Posts:
361 - 370
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube